Want to see IN:INDIAGLYCO full AI Analyst Report?
Top Page
India Glycols Limited
(INDIAGLYCO)
Select Model
Select Model
Rating:64Neutral
Price Target:
₹329.00
▼(-67.35% Downside)
Action:Reiterated
Date:09/10/26
The score is led by attractive valuation (low P/E) and a strong upward price trend versus key moving averages. This is balanced by a meaningful fundamental risk: persistently negative free cash flow and weak cash conversion, which reduces overall financial quality despite decent profitability and improving leverage.
Positive Factors
Revenue growth and profitability
The company has delivered strong multi-year revenue growth and remains profitable, with FY2026 revenue still increasing year over year and net margin around 7%. This combination supports ongoing reinvestment and indicates an established operating model across industrial and specialty chemical markets.
Negative Factors
Persistent negative free cash flow
Continued negative free cash flow shows that accounting profitability has not translated into cash available after investment spending. If this pattern persists, the company may have less internally generated funding for expansion, debt reduction, or shareholder returns, increasing reliance on external financing.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue growth and profitability
The company has delivered strong multi-year revenue growth and remains profitable, with FY2026 revenue still increasing year over year and net margin around 7%. This combination supports ongoing reinvestment and indicates an established operating model across industrial and specialty chemical markets.
Read all positive factors
India Glycols Limited (INDIAGLYCO) vs. iShares MSCI India ETF (INDA)
Market Cap
₹20.86B
Dividend Yield0.87%
Average Volume (3M)25.95K
Price to Earnings (P/E)6.0
Beta (1Y)1.26
Revenue Growth12.01%
EPS Growth23.71%
CountryIN
Employees1,409
SectorGeneral
Sector StrengthN/A
IndustryChemicals
Share Statistics
EPS (TTM)49.39
Shares Outstanding67,026,764
10 Day Avg. Volume45,124
30 Day Avg. Volume25,955
Financial Highlights & Ratios
PEG Ratio0.80
Price to Book (P/B)1.84
Price to Sales (P/S)1.28
P/FCF Ratio-31.34
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)13.88
Revenue Forecast (FY)₹45.76B
India Glycols Limited Business Overview & Revenue Model
Company Description
India Glycols Limited, a green petrochemical company, manufactures and sells industrial chemicals in India. It operates through Bio-based Specialities and Performance Chemicals, Potable Spirits, and Ennature Biopharma segments. The company offers ...
How the Company Makes Money
India Glycols Limited primarily makes money by manufacturing and selling chemicals to domestic and export customers. Its revenue model is product-sales driven, with earnings generated from (a) bulk/industrial chemicals and (b) higher-value special...
India Glycols Limited Financial Statement Overview
Summary
Income Statement
72
Positive
Balance Sheet
66
Positive
Cash Flow
38
Negative
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 43.01B | 42.11B | 37.68B | 32.94B | 26.37B | 28.68B |
| Gross Profit | 12.61B | 8.61B | 9.99B | 10.55B | 10.69B | 8.45B |
| EBITDA | 6.86B | 7.00B | 5.11B | 4.28B | 3.47B | 4.98B |
| Net Income | 3.16B | 2.93B | 2.31B | 1.73B | 1.25B | 3.40B |
Balance Sheet | ||||||
| Total Assets | 0.00 | 65.23B | 61.76B | 56.17B | 48.58B | 46.31B |
| Cash, Cash Equivalents and Short-Term Investments | 318.66M | 889.30M | 546.92M | 746.42M | 2.83B | 430.66M |
| Total Debt | 0.00 | 16.91B | 18.92B | 13.48B | 11.12B | 10.42B |
| Total Liabilities | -29.33B | 35.90B | 39.20B | 35.66B | 29.57B | 28.58B |
| Stockholders Equity | 29.33B | 29.33B | 22.56B | 20.51B | 19.01B | 17.92B |
Cash Flow | ||||||
| Free Cash Flow | -650.60M | -1.73B | -3.98B | -1.14B | -1.13B | -2.64B |
| Operating Cash Flow | 1.06B | 6.51B | 3.62B | 4.39B | 3.26B | 1.16B |
| Investing Cash Flow | -1.59B | -8.17B | -7.36B | -5.03B | -3.30B | 764.47M |
| Financing Cash Flow | 637.20M | 1.91B | 3.54B | 899.12M | -5.10M | -1.89B |
India Glycols Limited Technical Analysis
Positive
1007.65
Price Trends
240.33
Positive
223.97
Positive
209.83
Positive
Market Momentum
17.92
Negative
68.82
Neutral
7.92
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:INDIAGLYCO, the sentiment is Positive. The current price of 1007.65 is above the 20-day moving average (MA) of 254.41, above the 50-day MA of 240.33, and above the 200-day MA of 209.83, indicating a bullish trend. The MACD of 17.92 indicates Negative momentum. The RSI at 68.82 is Neutral, neither overbought nor oversold. The STOCH value of 7.92 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:INDIAGLYCO.
India Glycols Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | ₹11.03B | 7.38 | ― | 0.85% | 9.30% | 425.35% | |
65 Neutral | ₹446.19B | 55.41 | ― | 0.18% | 42.43% | 115.65% | |
64 Neutral | ₹20.86B | 5.97 | ― | 0.87% | 12.01% | 23.71% | |
63 Neutral | ₹528.27B | 85.79 | ― | 0.06% | 9.52% | -1.13% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
54 Neutral | ₹224.49B | 27.65 | ― | 0.47% | 8.20% | 29.06% | |
45 Neutral | ₹12.01B | 7,788.33 | ― | ― | 7.00% | ― |
* General Sector Average
IN:INDIAGLYCO
India Glycols Limited
295.70
125.33
73.56%
IN:DEEPAKNTR
Deepak Nitrite Limited
1,587.10
-154.59
-8.88%
IN:FLUOROCHEM
Gujarat Fluorochemicals Ltd.
4,771.75
1,061.93
28.62%
IN:GODAVARIB
Godavari Biorefineries Limited
235.20
-56.95
-19.49%
IN:GULPOLY
Gulshan Polyols Limited
175.40
15.06
9.39%
IN:NAVINFLUOR
Navin Fluorine International Limited
8,541.10
3,758.16
78.57%
India Glycols Limited Corporate Events
India Glycols Schedules Analyst and Institutional Investor Meeting in Mumbai
Aug 28, 2026
India Glycols Limited has scheduled a physical group meeting with analysts and institutional investors in Mumbai on Wednesday, 2 September 2026, starting at 5:00 p.m. IST. The company has cautioned that the schedule may change due to exigencies in...
India Glycols Sets August 19, 2026 Virtual AGM and Opens Digital Voting for Shareholders
Jul 24, 2026
India Glycols Limited has scheduled its 42nd Annual General Meeting for August 19, 2026 at 11:00 A.M. IST, to be held through video conferencing and other audio-visual means, and has released its Annual Report for the financial year 2025-26. The A...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.